Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIRECTA PLUS PLC Regulatory Filings 2020

Jul 27, 2020

7601_dva_2020-07-27_72733a8c-5d71-4470-a720-f53da7a8c7da.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2155U

Directa Plus PLC

27 July 2020

27 July 2020

Directa Plus plc

("Directa Plus" or the "Company")

Total Voting Rights

Directa Plus (AIM: DCTA) announces that the Company's issued share capital comprises 61,174,587 Ordinary Shares and the total number of voting rights in the Company is 61,174,587. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Further to the exercise of share options announced in early July, the Company realised that it was necessary to apply for the admission to trading on AIM of 1 additional new ordinary share ("Admission").  This additional share is included in the issued capital detailed above.  Such application has been made to the London Stock Exchange and it is expected that Admission will become effective at 8.00 a.m. on 31 July 2020.

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO
Marco Ferrari, CFO
Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker) +44 20 7894 7000
Rick Thompson, Philip Davies, Will Goode (Corporate Finance)
N+1 Singer (Joint Broker) +44 20 7496 3069
Mark Taylor
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson, Edward Lee

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVREDLFLBDLZBBX